Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1426 of 5804
-
Cash payments tested as tool to fight HIV disparities in the south
Disease control Recruiting nowUniversal Basic Income (UBI) is a promising strategy aimed at recalibrating economic systems that are grounded in structural racism. Black men have long been the target of oppressive and interconnected systems of finance and healthcare access, leading to a disproportionate burden…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New injection aims to tame chronic hepatitis b
Disease control CompletedThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of AHB-137 subcutaneous injection in healthy participants after single and multiple doses, and evaluate the preliminary efficacy of AHB-137 in CHB participants after up to 24 weeks of treatmen…
Phase: PHASE1, PHASE2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a common drug improve stem cell transplants for a rare bone marrow cancer?
Disease control Recruiting nowThis is a single site, open-label, dose de-escalation, Phase 1 study of pegylated interferon alfa-2a administered after alloHCT in subjects with primary or secondary myelofibrosis. Part 1 of the study will assess the rate of dose-limiting toxicities (DLTs) during the DLT evaluati…
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could zapping the brain help treat anorexia? new trial investigates
Symptom relief Recruiting nowPreliminary open-label studies have suggested that non-invasive brain stimulation methods of both transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS) have clinical benefits for improving psychological and eating disorder related …
Phase: NA • Sponsor: The George Institute • Aim: Symptom relief
Last updated Jun 26, 2026 15:26 UTC
-
New antibody drug shows early promise for Hard-to-Treat blood cancers
Disease control CompletedThis is a phase I, multicenter, open label, sequential-cohort, dose escalation study of ESG206. The purpose is to evaluate the clinical safety, tolerability, PK (pharmacokinetics), and preliminary efficacy and to establish the MTD (maximum tolerated dose), if any, and RP2D (recom…
Phase: PHASE1 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 15:36 UTC
-
New combo targets Hard-to-Treat cancers with missing gene
Disease control CompletedThe main aims of this study are to evaluate the safety and tolerability, and to determine the maximum tolerated dose (MTD) or the recommended combination dose of Anvumetostat in combination with IDE397 in adult participants with metastatic or locally advanced MTAP-null solid tumo…
Phase: PHASE1, PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could Botox-Like shots ease diabetic foot pain?
Symptom relief Recruiting nowThe goal of this clinical trial is to test perineural injections (injections around a nerve) of incobotulinumtoxin-A in participants with diabetic nerve pain of the feet and lower legs. The main questions it aims to answer are: * Is the treatment safe and effective? * Does the …
Phase: PHASE2 • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for youth: school program targets suicide thoughts in rural india
Symptom relief OngoingIt is Cluster Randomized Control Trial research to examine feasibility and relevance of the modified tool Nae Disha for Life, which will incorporate suicide prevention and resilience to reduce suicide ideation among young people in Bundelkhand region of Madhya Pradesh, India. Thi…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Sleep therapy may cut diabetes risk in prediabetes patients
Disease control Recruiting nowThis study tests whether providing cognitive behavioral therapy for insomnia (CBT-I) to people with prediabetes results in a reduction in glucose levels compared to a patient education control program.
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New ADHD drug shows promise for kids in Late-Stage trial
Symptom relief CompletedA Phase 3, randomized, double-blind, placebo-controlled, multi-center, fixed-dose, parallel-group efficacy and safety study in a pediatric population (6-17) with Attention-Deficit/Hyperactivity Disorder (ADHD) using CTx-1301 (d-MPH). The study will be comprised of a screening per…
Phase: PHASE3 • Sponsor: Cingulate Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New vaccine aims to shield leukemia patients from COVID-19
Disease control TerminatedThis phase II trial compares the effect of the GEO-CM04S1 vaccine with the current standard of care vaccine in preventing COVID-19 infections in patients with chronic lymphocytic leukemia (CLL). The GEO-CM04S1 vaccine uses a modified vaccinia virus (MVA) backbone that may be more…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Simple breathing exercises cut frailty in elderly COPD patients
Symptom relief CompletedPurpose: This study evaluated the impact of a structured intervention on frailty, lung function, physical capacity, and dyspnea in elderly COPD patients. COPD, common in older adults, often coexists with frailty, which worsens health outcomes. While pulmonary rehabilitation impro…
Phase: NA • Sponsor: Çankırı Karatekin University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Inhaled drug shows promise for stopping lung bleeding in kids
Disease control CompletedThis study aimed to detect the impact of inhaled Tranexamic acid® in pulmonary hemorrhage in pediatric intensive care unit.
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a gentle zapping of the brain ease MS fatigue and brain fog?
Symptom relief CompletedMultiple sclerosis (MS) is a chronic, inflammatory and disabling disease of the Cnetral Nervous System characterized by relapsing and / or progressive somatosensory, motor and vestibular clinical manifestations. Moreover, fatigue, depression, anxiety, and cognitive impairment are…
Phase: NA • Sponsor: Universidad de Almeria • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New mRNA boosters aim to strengthen COVID-19 protection
⭐️ VACCINE ⭐️ CompletedThe purpose of Part A of this study is to assess the immune response and safety of a booster dose of investigational COVID-19 mRNA vaccines in healthy adults. The study will compare the investigational vaccines to control vaccine. The purpose of Part B of this study is to assess…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:55 UTC
-
Combination therapy aims to boost blood cells in Hard-to-Treat MDS
Disease control TerminatedRoxadustat has been approved for low-risk MDS clinical trials, but the trial results are not available. For refractory low-risk MDS, the effective rate of roxadustat treatment is about 20-30%, and roxadustat combined with retinoic acid may have better efficacy in the treatment of…
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Heart rhythm showdown: which ablation strategy wins for persistent AF?
Disease control CompletedThis is a prospective, randomized, multi-center trial that aims to investigate whether termination of atrial fibrillation can be used as an ablation endpoint for persistent atrial fibrillation (PersAF). Eligible patients who provided consent were randomly assigned to one of two g…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:33 UTC
-
Could an antibody finally treat long COVID?
Disease control OngoingPersistent viral infection with viral reservoirs and detection of circulating spike protein after the initial acute illness is one potential pathogenic mechanism for Long COVID. This mechanism may be able to be targeted by SARS-CoV-2 monoclonal antibodies (mAbs). This trial will …
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New strategy aims to get lifesaving heart drugs to more patients
Disease control CompletedHeart failure with reduced ejection fraction (HFrEF) is associated with high mortality and adverse events (hospitalization or urgent outpatient visits for HF), along with diminished quality of life. Despite convincing data that evidenced-based, guideline-directed medical therapie…
Phase: NA • Sponsor: Geisinger Clinic • Aim: Disease control
Last updated Jun 26, 2026 19:11 UTC
-
Exercise may sharpen aging minds in HIV patients
Symptom relief Recruiting nowPeople aging with HIV are at higher risk for Alzheimer's disease and related dementias, and although physical activity is a promising target to mitigate such risk, this population engages in low levels of physical activity. Few studies have tested cognitive effects of exercise in…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC